IBDEI0KN ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10118,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,10118,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,10118,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,10119,0)
 ;;=V10.03^^67^672^60
 ;;^UTILITY(U,$J,358.3,10119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10119,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,10119,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,10119,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,10120,0)
 ;;=V10.60^^67^672^62
 ;;^UTILITY(U,$J,358.3,10120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10120,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,10120,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,10120,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,10121,0)
 ;;=V10.11^^67^672^63
 ;;^UTILITY(U,$J,358.3,10121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10121,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,10121,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,10121,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,10122,0)
 ;;=V10.79^^67^672^64
 ;;^UTILITY(U,$J,358.3,10122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10122,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,10122,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,10122,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,10123,0)
 ;;=V10.82^^67^672^65
 ;;^UTILITY(U,$J,358.3,10123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10123,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,10123,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,10123,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,10124,0)
 ;;=V10.02^^67^672^68
 ;;^UTILITY(U,$J,358.3,10124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10124,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,10124,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,10124,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,10125,0)
 ;;=V10.43^^67^672^69
 ;;^UTILITY(U,$J,358.3,10125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10125,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,10125,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,10125,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,10126,0)
 ;;=V10.46^^67^672^70
 ;;^UTILITY(U,$J,358.3,10126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10126,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,10126,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,10126,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,10127,0)
 ;;=V10.06^^67^672^71
 ;;^UTILITY(U,$J,358.3,10127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10127,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,10127,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,10127,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,10128,0)
 ;;=V10.52^^67^672^72
 ;;^UTILITY(U,$J,358.3,10128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10128,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,10128,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,10128,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,10129,0)
 ;;=V10.04^^67^672^74
 ;;^UTILITY(U,$J,358.3,10129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10129,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,10129,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,10129,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,10130,0)
 ;;=V10.47^^67^672^75
 ;;^UTILITY(U,$J,358.3,10130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10130,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,10130,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,10130,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,10131,0)
 ;;=V10.83^^67^672^73
 ;;^UTILITY(U,$J,358.3,10131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10131,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,10131,1,5,0)
 ;;=5^H/O Skin Cancer
